BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Aspirin
,
rs2476601
,
IL1A
,
cell-cell adhesion
,
HIV infection
,
Heart
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IFNα
Summary
General Info
Curated Studies
Most Correlated Studies
Embryonic fibroblasts with RICTOR knockout treated with IFNa
Huh7 hepatoma cells treated with IFNa2 and Oncostatin M
Ovarian cancer OVCAR-3 cells treated with natural product Fusicoccin A and IFNalpha
Macrophages lacking Stat1, treated with IFN-gamma and infected with L. monocytogenes
Type 2 conventional dendritic cells (cDC2s) CD1C+ of primary Sjogren's sicca & non-Sjogren's sicca
Explore Curated Studies Results
Literature
Most Relevant Literature
Constitutive IFNα Protein Production in Bats.
Mesenchymal stromal cells equipped by IFNα empower T cells with potent anti-tumor immunity.
IFNα Potentiates Immune-Checkpoint Blockade by Rewiring Metabolic Cross-talk.
IFNα induces CCR5 in CD4+ T-cells, causing its anti- HIV inefficiency and its subsequent pathogenic …
ISR8/IRF1-AS1 Is Relevant for IFNα and NF-κB Responses.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection
A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ov…
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC
Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chr…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ